Technical Analysis for SCPH - scPharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 2.92 1.39% 0.04
SCPH closed up 1.39 percent on Tuesday, February 19, 2019, on 1.27 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SCPH trend table...

Date Alert Name Type % Chg
Feb 19 Stochastic Buy Signal Bullish 0.00%
Feb 19 Lower Bollinger Band Walk Weakness 0.00%
Feb 19 New 52 Week Low Weakness 0.00%
Feb 19 Wide Bands Range Expansion 0.00%
Feb 19 Lower Bollinger Band Touch Weakness 0.00%
Feb 19 Oversold Stochastic Weakness 0.00%
Feb 15 New 52 Week Closing Low Bearish 1.39%
Feb 15 Lower Bollinger Band Walk Weakness 1.39%
Feb 15 New 52 Week Low Weakness 1.39%
Feb 15 Wide Bands Range Expansion 1.39%

Older signals for SCPH ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.
Medicine Biopharmaceutical Drugs Chemical Compounds Medication Pharmaceutical Products Dosage Forms Heart Failure Chloroarenes Injection Intravenous Therapy
Is SCPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.955
52 Week Low 2.76
Average Volume 35,242
200-Day Moving Average 5.7349
50-Day Moving Average 3.9571
20-Day Moving Average 3.576
10-Day Moving Average 3.334
Average True Range 0.2576
ADX 15.99
+DI 14.779
-DI 31.6379
Chandelier Exit (Long, 3 ATRs ) 3.4872
Chandelier Exit (Short, 3 ATRs ) 3.5328
Upper Bollinger Band 4.2753
Lower Bollinger Band 2.8767
Percent B (%b) 0.03
BandWidth 39.110738
MACD Line -0.2493
MACD Signal Line -0.1761
MACD Histogram -0.0732
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.21
Resistance 3 (R3) 3.18 3.07 3.16
Resistance 2 (R2) 3.07 2.99 3.08 3.14
Resistance 1 (R1) 2.99 2.95 3.03 3.02 3.13
Pivot Point 2.88 2.88 2.90 2.89 2.88
Support 1 (S1) 2.80 2.80 2.84 2.83 2.71
Support 2 (S2) 2.69 2.76 2.70 2.70
Support 3 (S3) 2.61 2.69 2.68
Support 4 (S4) 2.64